These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32575932)

  • 21. [Effect of splenic hilar lymphadenectomy on locally advanced Siewert type Ⅱ and Ⅲ adenocarcinoma of esophagogastric junction with a tumor diameter ≥4 cm: a five-year survival analysis].
    Lin JX; Wu D; Jiang YM; Chen JY; Lin GT; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Zheng CH; Huang CM
    Zhonghua Wai Ke Za Zhi; 2022 Sep; 60(9):853-859. PubMed ID: 36058712
    [No Abstract]   [Full Text] [Related]  

  • 22. Feasibility of laparoscopic total gastrectomy for advanced Siewert type Ⅱ and type Ⅲ esophagogastric junction carcinoma: A propensity score-matched case-control study.
    Zhao Y; Zhang J; Yang D; Tang Z; Wang Q
    Asian J Surg; 2019 Aug; 42(8):805-813. PubMed ID: 30685144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
    Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction.
    Sugita S; Kinoshita T; Kaito A; Watanabe M; Sunagawa H
    Surg Endosc; 2018 Jan; 32(1):383-390. PubMed ID: 28656339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adenocarcinoma of the esophagogastric junction: retrospective analysis of 39 patients].
    Butte JM; Becker F; Visscher A; Waugh E; Meneses M; Court I; Parada H; DE LA Fuente H
    Rev Med Chil; 2010 Jan; 138(1):53-60. PubMed ID: 20361151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in prognosis of Siewert II and III oesophagogastric junction cancers are determined by the baseline tumour staging but not its anatomical location.
    Kulig P; Sierzega M; Pach R; Kolodziejczyk P; Kulig J;
    Eur J Surg Oncol; 2016 Aug; 42(8):1215-21. PubMed ID: 27241921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymph Node Ratio Is an Independent Prognostic Factor for Patients with Siewert Type II Adenocarcinoma of Esophagogastric Junction: Results from a 10-Year Follow-up Study.
    Zhang Y; Liu D; Zeng D; Chen C
    J Gastrointest Cancer; 2021 Sep; 52(3):983-992. PubMed ID: 32954465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of preoperative concurrent chemoradiotherapy with chemotherapy alone in patients with locally advanced siewert II and III adenocarcinoma of the esophagogastric junction.
    Ge X; Zhao Q; Song Y; Li J; Liu M; Bai W; Qiao X
    Eur J Surg Oncol; 2018 Apr; 44(4):502-508. PubMed ID: 29395438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proximal Gastrectomy versus Total Gastrectomy for Siewert Type II Adenocarcinoma of the Esophagogastric Junction: A Comprehensive Analysis of Data from the SEER Registry.
    Zhu K; Xu Y; Fu J; Mohamud FA; Duan Z; Tan S; Zhao Z; Chen P; Zong L
    Dis Markers; 2019; 2019():9637972. PubMed ID: 31976023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diffuse-Type Histology Is Prognostic for All Siewert Types of Gastroesophageal Adenocarcinoma.
    Mahuron KM; Sullivan KM; Hernandez MC; Chen YJ; Chao J; Melstrom LG; Paz IB; Kim JY; Mannan R; Lin JL; Fong Y; Woo Y
    J Gastric Cancer; 2024 Jul; 24(3):267-279. PubMed ID: 38960886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adenocarcinomas of the esophagogastric junction: experiences at a single institution in China.
    Zhang H; Wang W; Cheng Y; Song Y; Zhu K; Dang C
    World J Surg Oncol; 2013 Jul; 11():155. PubMed ID: 23849250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of prognostic compatibility between seventh AJCC/TNM of the esophagus and 14th JCGC staging systems in Siewert type II adenocarcinoma.
    Kawaguchi T; Komatsu S; Ichikawa D; Kubota T; Okamoto K; Shiozaki A; Fujiwara H; Konishi H; Morimura R; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Sakakura C; Otsuji E
    Anticancer Res; 2013 Aug; 33(8):3461-5. PubMed ID: 23898120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term outcomes and prognostic factor analysis of resected Siewert type II adenocarcinoma of esophagogastric junction in China: a seven-year study.
    Feng Y; Jiang Y; Zhao Q; Liu J; Zhang H; Chen Q
    BMC Surg; 2020 Nov; 20(1):302. PubMed ID: 33256690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of the effect of lymph node dissection performed by Ivor-Lewis or left-sided thoracic esophagogastrectomy for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction].
    Duan XF; Gong L; Ma MQ; Yue J; Tang P; Shang XB; Jiang HJ; Yu ZT
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):190-194. PubMed ID: 28316217
    [No Abstract]   [Full Text] [Related]  

  • 36. [Proximal incisal edge length and recent clinical observation of Siewert type Ⅱ advanced esophagogastric junction adenocarcinoma].
    Mei XH; Wang YY; Guo W; Li Y; Wang ZB; Bi ZP; He D; Su M; Han JJ; Zhang XW; Qin X
    Zhonghua Yi Xue Za Zhi; 2021 Sep; 101(34):2698-2702. PubMed ID: 34510876
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prognostic significance of the number of dissected lymph nodes in Siewert type Ⅱadenocarcinoma of the esophagogastric junction without lymphatic metastasis].
    Wang JQ; Wei DZ; Xie MR; Xu SB; Ma DC
    Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):300-4. PubMed ID: 27087378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor size predicts worse prognosis in esophagogastric junction adenocarcinoma.
    Takeda FR; Ramos MFKP; Pereira MA; Sallum RAA; Ribeiro Junior U; Nahas SC; Cecconello I
    Updates Surg; 2022 Dec; 74(6):1871-1879. PubMed ID: 35776245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laparoscopic-assisted versus open total gastrectomy for Siewert type II and III esophagogastric junction carcinoma: a propensity score-matched case-control study.
    Huang CM; Lv CB; Lin JX; Chen QY; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Cao LL; Lin M; Tu RH
    Surg Endosc; 2017 Sep; 31(9):3495-3503. PubMed ID: 27981384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.